EGFR activation sensitizes trigeminal NMDA receptors to promote pain and morphine analgesic tolerance in oral cancer
Science Signaling · 2026
DOI: 10.1126/scisignal.adt3026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, 2026. Verfasst von Naijiang Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Translational Research Center, College of Dentistry, New York University, New York, NY 10010, USA. Hauptthemen laut MEDLINE: ErbB Receptors, Receptors, N-Methyl-D-Aspartate, Morphine, Cancer Pain. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS, NINDS NIH HHS, National Institute of Dental and Craniofacial Research.
Abstract (Originalsprache)
Pain associated with oral cancer is debilitating. Opioids are the gold standard for cancer pain management, but tolerance and side effects limit their use. Epidermal growth factor receptor (EGFR) signaling is commonly amplified in oral tumors. Here, we found that EGFR activation contributed to both oral cancer pain and opioid tolerance by sensitizing trigeminal ganglion (TG) cells, the main sensory neurons innervating the face and mouth. EGFR ligands were secreted by oral squamous cell carcinoma (OSCC) cells and by peripheral glial cells cocultured with OSCC cells. In human OSCC and an orthotopic mouse model, EGFR was abundant in tumor-innervating TG nerves. Oral cancer pain and opioid tolerance in the mice were increased by EGFR ligands and reduced by EGFR inhibitors. In mice, the abundance of glutamate-type NMDA receptors (NMDARs) was also increased in both the TG and the brainstem. Upon activation by ligands or OSCC cell supernatant, EGFR phosphorylated the NMDAR subunit GluN2B, which increased electrical currents and sensitized pre- and postsynaptic NMDARs in the brainstem. This sensitization was also seen in the brainstems of mice receiving chronic morphine treatment and was mitigated by EGFR blockade. These findings suggest that EGFR-targeted cancer therapeutics may be repurposed to manage cancer pain and reduce opioid tolerance in patients with OSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Translational Research Center, College of Dentistry, New York University, New York, NY 10010, USA.
- Pain Research Center, Department of Molecular Pathobiology, College of Dentistry, New York University, New York, NY 10010, USA.
- Division of Anesthesiology, Critical Care Medicine, and Pain Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Loma Linda University School of Dentistry, Loma Linda, CA 92350, USA.
- Head & Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Department of Neuroscience, Grossman School of Medicine, New York University, New York, NY 10010, USA.
ORCID-Profile: Naijiang Liu, Shao-Rui Chen, Maria Daniela Santi, Minh Phuong Dong, Maria Fernanda Pessano Fialho, Frederico Gleber-Netto, Rocco Latorre, Nigel W Bunnett, Hui-Lin Pan, Yi Ye
Förderung
- NIDCR NIH HHS
- NINDS NIH HHS
- National Institute of Dental and Craniofacial Research
- NIDCR
Zitieren
APA
Liu, N., Shi, X., Chen, S. R., Chen, H., Santi, M. D., Dong, M. P., Fialho, M. F. P., Xie, T., Gleber-Netto, F., Latorre, R., Bunnett, N. W., Viet, C. T., Amit, M., Pan, H. L., & Ye, Y. (2026). EGFR activation sensitizes trigeminal NMDA receptors to promote pain and morphine analgesic tolerance in oral cancer. Science Signaling. https://doi.org/10.1126/scisignal.adt3026
Vancouver
Liu N, Shi X, Chen SR, Chen H, Santi MD, Dong MP, et al. EGFR activation sensitizes trigeminal NMDA receptors to promote pain and morphine analgesic tolerance in oral cancer. Science Signaling. 2026. doi:10.1126/scisignal.adt3026
BibTeX
@article{Liu2026,
author = {Liu, Naijiang and Shi, Xiaojie and Chen, Shao-Rui and Chen, Hong and Santi, Maria Daniela and Dong, Minh Phuong and Fialho, Maria Fernanda Pessano and Xie, Tongxin and Gleber-Netto, Frederico and Latorre, Rocco and Bunnett, Nigel W and Viet, Chi T and Amit, Moran and Pan, Hui-Lin and Ye, Yi},
title = {EGFR activation sensitizes trigeminal NMDA receptors to promote pain and morphine analgesic tolerance in oral cancer},
journal = {Science Signaling},
year = {2026},
doi = {10.1126/scisignal.adt3026}
}
EUVIMED